We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results: 1-10 of 1,293

Life sciences & law current issues 201213
  • Gowling Lafleur Henderson LLP
  • Canada, European Union, USA
  • June 18 2012

Each stage of the life cycle of a company or a product presents challenges that demand the expertise and resources of a strong legal partner

E.U. way ahead of the game on telehealth
  • Epstein Becker Green
  • European Union, USA
  • March 21 2013

Telehealth is expanding rapidly outside of the U.S. in both developed and developing countries. Not surprisingly, the expanded use of telehealth

The EFPIA and PhRMA principles for responsible sharing of clinical trial data enter into force on 1 January 2014
  • Hogan Lovells
  • European Union, USA
  • January 7 2014

On 1 January 2014, the joint Principles for Responsible Clinical Trial Data Sharing ("the Principles") endorsed by the European Federation of

Tribunals and the Court of Justice of the European Union consider whether sick workers can carry over statutory holiday andor holiday pay
  • Jones Day
  • European Union, United Kingdom, USA
  • January 3 2012

In Adams and another v Harwich International Port Ltd, an employment tribunal held that sick workers may carry over their statutory annual leave entitlement until the next leave year (but not necessarily beyond) if unable or unwilling to take it due to sickness or if so required by the employer

Navigating the evolving regulation and commercialization of stem cell research
  • McDermott Will & Emery
  • European Union, USA
  • March 22 2012

Interested parties that can successfully navigate the evolving regulation of stem cell research stand to gain significant scientific and commercial advantage

New route for cooperation between the E.U. and the U.S. on biosimilars
  • Dechert LLP
  • European Union, USA
  • June 28 2011

The European Medicines Agency (EMA) and the United States Food and Drug Administration (FDA) have set up a new “cluster” on biosimilar medicines

EU, US regulators ease process for orphan drugs
  • Gowling Lafleur Henderson LLP
  • European Union, USA
  • December 6 2007

In an effort to encourage development of drug treatments for rare diseases, the European Commission, the European Medicines Agency and the U.S. Food and Drug Administration announced steps to streamline the application process for orphan drugs

Joint public meeting to focus on bridging nanotechnology research
  • Shook Hardy & Bacon LLP
  • European Union, USA
  • February 24 2011

The National Nanotechnology Coordination Office has announced that it will spearhead a public meeting to focus on "environmental health and safety questions for nanomaterials and nanotechnology-enabled products" and to "encourage joint US-EU programs of work that would leverage resources."

What you need to know about the law relating to the marketing of dietary supplements in the U.S., the EU and China
  • Kelley Drye & Warren LLP
  • China, European Union, USA
  • July 22 2011

Consumers around the world are increasing their use of dietary supplements

EMEA and FDA focus on clinical research safety and enforcement
  • McDermott Will & Emery
  • European Union, USA
  • August 20 2009

Recent policy changes emphasize the need for sponsoring organizations to be even more vigilant in establishing, updating and monitoring their systems for compliance with clinical research requirements, whether conducted domestically or in a foreign locale